Interim 4′-[methyl-11C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [18F]FDG PET

Volume: 11, Issue: 1
Published: Feb 10, 2021
Abstract
Purpose We investigated the potential of interim 4′-[methyl- 11 C]thiothymidine ([ 11 C]4DST) PET for predicting the chemoradiotherapeutic response for head and neck squamous cell carcinoma (HNSCC), in comparison with 2-deoxy-2-[ 18 F]fluoro-D-glucose ([ 18 F]FDG) PET. Methods A total of 32 patients with HNSCC who underwent both [ 11 C]4DST and [ 18 F]FDG PET/CT before therapy (baseline) and at approximately 40 Gy point during chemoradiotherapy...
Paper Details
Title
Interim 4′-[methyl-11C]-thiothymidine PET for predicting the chemoradiotherapeutic response in head and neck squamous cell carcinoma: comparison with [18F]FDG PET
Published Date
Feb 10, 2021
Volume
11
Issue
1
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.